VB

Valerie Bertele

Global Director of Growth at BairesDev

San Francisco, California

Overview

Work Experience

  • Global Director of Growth

    2024 - Current

  • Strategic Advisor

    2024

    Frontier tech. New approach to AI based on digital biology.

  • General Partner

    2019

    Early-stage venture fund in San Francisco.

  • Business Development / Partnerships / Account Management

    2019 - 2023

    Working with Alphabet/Google on the vendor side responsible for Growth, Client Relationship/Engagement, as well as Business Development including opening new countries and locations for Google and GCP Partnerships.

  • Head of Growth

    2021 - 2023

    Digital Transformation > B2B Sales, Business Development, Partnerships and Alliances, Global Expansion, Go to Market Strategy

  • Senior Account Manager | HCLS | Global Google Programs

    2019 - 2021

    Google Program Management including Business Development of existing and new opportunities Google Cloud HCLS strategy

  • Territory Manager (Sales and Business Development + Clinical Support)

    2017 - 2019

    - 2018 Country Top Achievers Award nomination in Business Development - Responsible for 2 states, one of them is the biggest state - NSW, covering 32 hospitals - Managed projects for setting up complex Capital Equipment installations, working with external Public and Private Hospitals’ teams and internal cross-functional teams - Provided expert clinical and technical assistance in Electrophysiology Managed Sales and Business Development of RHYTHMIA™ Advanced Cardiac Mapping System, including Hardware and unique Software, featuring a continuous cardiac mapping algorithm that rapidly processes a high volume of data in order to create high-definition electro-anatomical 3D maps of heart chambers, valves, and vessels.

  • Invited Scientist/PhD candidate (Immuno-Oncology)

    2016 - 2017

    Cancer Division, Immunobiology of Cancer I dropped out to study data science, Python, machine learning, and AI. Invited for a PhD project: Immunotherapy. Coevolution of tumour and the immune system in osteosarcoma development and progression. Genomic instability and checkpoint blockade (PD-1 pathway).

  • Founder (Exit)

    2011 - 2016

    Moved to China and started a company after learning Chinese language in 4 month. Sold after leaving China. Delivered multiple cross-functional projects managing the full process from scouting to closing the deal. Activities include Chinese market research and expansion, establishment of sourcing entities, supply chain, logistics, QA/QC, process improvements, strategy. Last years work moved towards eCommerce, We Chat and other Chinese Social Media Platforms, Chinese consumers behavior, Marketing Consulting, Digital Marketing, Content Strategy, Social Media Marketing.

Relevant Websites